In sepsis-associated ARDS, glucocorticoid selection and dose are associated with survival. Methylprednisolone and dexamethasone were associated with lower mortality compared to hydrocortisone, while high-dose therapy was linked to increased mortality.
Huang et al. (Fri,) studied this question.